Join the 155,000+ IMP followers

Bayer News

Bayer AG, founded in 1863 and headquartered in Leverkusen, Germany, is a global enterprise with core competencies in the life science fields of healthcare and agriculture. The company's operations are divided into three main segments: Pharmaceuticals, focusing on prescription products primarily for cardiology and women's healthcare; Consumer Health, offering over-the-counter medications and health products; and Crop Science, providing innovative solutions for seeds, crop protection, and pest control. Bayer is committed to sustainability and innovation, aiming to improve the quality of life by preventing, alleviating, and treating diseases, as well as ensuring a reliable food supply. With a presence in over 90 countries, Bayer employs approximately 100,000 people worldwide, dedicated to advancing health and nutrition.
  www.bayer.com
  • 1
  • 2
24  '24
Written on

Bayer to present real-world study data of Kerendia (finerenone)

Bayer will present data on Kerendia™ (finerenone) use among patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) in real-world clinical practice, as well as new risk models for patients with CKD and T2D at the 61st European Renal Association (ERA) Congress.

  • 1
  • 2

Join the 155,000+ IMP followers

International